Hudson Robotics Inc. announced today that the groundbreaking Protean Workcell has been released as a new product for automating drug discovery and genomics applications for pharmaceutical and biotech companies, universities and research institutes.
Hudson Robotics Inc. announced today that the groundbreaking Protean Workcell has been released as a new product for automating drug discovery and genomics applications for pharmaceutical and biotech companies, universities and research institutes.
What issues does the Protean Workcell address? Laboratory space is expensive and always in short supply. Research modalities are constantly evolving and changing. Discovery procedures are complex in their scope, timing and the precision required. The Protean Workcell is designed to address these issues of available space and system flexibility:
- Laboratory Space - By making better use of vertical space and allowing instruments to be stacked up to three high, the Protean Workcell provides for maximum efficiency in instrument density in a minimum footprint.
- System Software and Hardware Flexibility – Driven by the world’s most powerful and open automation software, SoftLinx™, methods can be created or modified quickly by users; Protean system architecture is equally as flexible, allowing instruments and modules to be quickly and easily swapped or replaced, quickly facilitating new workflow functionalities.
Hudson Robotics provides microplate and liquid-handling automation solutions in the fields of drug discovery, genomics and diagnostics, and has a comprehensive tool kit to assist you with any small, medium or large-scale automation project. Learn more about the Protean Workcell including a video by clicking here.